Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors
Clinical trial NCT06195293 · RECRUITING
Trial details
- NCT number
- NCT06195293
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2029-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.